Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide

JAMA Dermatol. 2013 Aug;149(8):992-3. doi: 10.1001/jamadermatol.2013.4399.

Authors

Xiaodong Li¹, Yuxiao Hong, Qian An, John Chen, Huachen Wei, Hong-Duo Chen, Xing-Hua Gao

Affiliation

¹ Fengtian Hospital Affiliated with Shenyang Medical College, Shenyang, China2Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang.

PMID: 23783880
DOI: 10.1001/jamadermatol.2013.4399

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Adult
Dose-Response Relationship, Drug
Follow-Up Studies
Histiocytosis, Sinus / drug therapy*
Histiocytosis, Sinus / pathology
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use*
Male
Skin Diseases / drug therapy*
Skin Diseases / pathology
Thalidomide / administration & dosage
Thalidomide / therapeutic use*
Treatment Outcome

Substances

Immunosuppressive Agents
Thalidomide